“…To this end, the use of bacterial cellulose (BC), produced by microbial cells ( Ullah et al, 2017 ) and cell-free systems ( Ullah et al, 2015 ; Kim et al, 2019 ), has received a growing interest as a biomaterial in various biomedical applications ( Klemm et al, 2001 ; Czaja et al, 2006 ; Khan et al, 2015a , b ; Hussain et al, 2019 ), specialty membrane ( Rajwade et al, 2015 ), biosensors ( Jasim et al, 2017 ; Farooq et al, 2020 ), and drug release ( Numata et al, 2015 ; Li et al, 2018 ). These applications utilize both pure BC and its composites with other materials, such as biopolymers including collagen ( Takeda et al, 2016 ), silk-sericin ( Lamboni et al, 2016 ), gelatin ( Khan et al, 2018 ), alginate ( Kirdponpattara et al, 2015 ), and chitosan ( Ul-Islam et al, 2019 ), and nanoparticles such as silver ( Maneerung et al, 2008 ), zinc ( Ul-Islam et al, 2014 ; Khalid et al, 2017a ), titanium dioxide ( Khan et al, 2015a , b ; Ullah et al, 2016a ; Khalid et al, 2017b ), and gold ( Khan et al, 2018 ), as well as clay materials such as pristine and modified montmorillonite ( Ul-Islam et al, 2013b ). The unique features of BC include high purity, better mechanical properties, high water holding capacity (WHC) and slow water release rate (WRR), active surface area, moderate biocompatibility, biodegradability, three-dimensional (3D) reticulate fibrous structure, micro-porosity, optical transparency, and non-toxicity, and moldability into different shapes ( Czaja et al, 2006 ; Ul-Islam et al, 2013a ; Ullah et al, 2016b ; Di et al, 2017 ).…”